KRAS-mutated non-small cell lung cancer: new therapy strategies

Автор: Laktionov K.K., Sarantseva K.A., Nelyubina L.A., Gamayunov S.V., Kolesnikova E.A., Gordiev M.G.

Журнал: Сибирский онкологический журнал @siboncoj

Рубрика: Опыт работы онкологических учреждений

Статья в выпуске: 2 т.23, 2024 года.

Бесплатный доступ

Lung cancer remains one of the most dangerous and most common cancers, requiring constant improvement of diagnostic and treatment methods. The genetic heterogeneity of lung cancer forces us to search for new therapeutic targets in an attempt to achieve greater effectiveness for certain groups of patients. The purpose of the study was to update current knowledge about lung adenocarcinoma with a mutation in the KRAS gene, to consider new opportunities for personalized treatment of KRAS-mutated NSCLC and to form an image of a Russian patient who is potentially indicated for targeted therapy. Material and Methods. A search of available literature sources published in the Pubmed, Cochrane Library, Elibrary database was carried out, publications covering the period from 2008 to 2023 were included.

Еще

Nsclc, molecular genetic testing, kras, kras g12c, sotorasib, ngs

Короткий адрес: https://sciup.org/140305912

IDR: 140305912   |   DOI: 10.21294/1814-4861-2024-23-2-72-81

Статья научная